USD 2.75
(0.37%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 5.73 Million USD | 74.31% |
2022 | 3.28 Million USD | 3014.0% |
2021 | 105.65 Thousand USD | 344.45% |
2020 | 23.77 Thousand USD | 49.41% |
2019 | 15.91 Thousand USD | 0.0% |
2018 | - USD | 100.0% |
2017 | -9667.00 USD | 0.0% |
2016 | - USD | 100.0% |
2015 | -3111.00 USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 7.69 Million USD | 34.23% |
2024 Q2 | 8.49 Million USD | 10.3% |
2023 Q1 | 3.7 Million USD | 12.77% |
2023 Q2 | 4.25 Million USD | 14.58% |
2023 FY | 5.73 Million USD | 74.31% |
2023 Q4 | 5.73 Million USD | 26.96% |
2023 Q3 | 4.51 Million USD | 6.26% |
2022 Q2 | 205.37 Thousand USD | 13.15% |
2022 FY | 3.28 Million USD | 3014.0% |
2022 Q3 | 269.64 Thousand USD | 31.29% |
2022 Q1 | 181.49 Thousand USD | 71.79% |
2022 Q4 | 3.28 Million USD | 1120.12% |
2021 FY | 105.65 Thousand USD | 344.45% |
2021 Q1 | 26.66 Thousand USD | 12.15% |
2021 Q3 | 71.31 Thousand USD | 57.71% |
2021 Q2 | 45.21 Thousand USD | 69.61% |
2021 Q4 | 105.65 Thousand USD | 48.16% |
2020 Q1 | 13.71 Thousand USD | -13.82% |
2020 FY | 23.77 Thousand USD | 49.41% |
2020 Q3 | 26.2 Thousand USD | 58.07% |
2020 Q4 | 23.77 Thousand USD | -9.27% |
2020 Q2 | 16.57 Thousand USD | 20.89% |
2019 FY | 15.91 Thousand USD | 0.0% |
2019 Q3 | 17.77 Thousand USD | -2.28% |
2019 Q2 | 18.19 Thousand USD | 37.44% |
2019 Q1 | 13.23 Thousand USD | 0.0% |
2019 Q4 | 15.91 Thousand USD | -10.51% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 100.0% |
2018 Q1 | - USD | 100.0% |
2018 Q4 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | -9667.00 USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | -9667.00 USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q1 | -103.15 Thousand USD | -3215.81% |
2016 FY | - USD | 100.0% |
2016 Q4 | - USD | 100.0% |
2016 Q3 | -1006.00 USD | 0.0% |
2016 Q2 | - USD | 100.0% |
2015 FY | -3111.00 USD | 0.0% |
2015 Q4 | -3111.00 USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Theratechnologies Inc. | 6.06 Million USD | 5.461% |
Harrow Health, Inc. | 10.86 Million USD | 47.228% |
Dynavax Technologies Corporation | 53.29 Million USD | 89.239% |
Biofrontera Inc. | 10.9 Million USD | 47.426% |
Cronos Group Inc. | 30.33 Million USD | 81.098% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -110.914% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -573475400.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -0.627% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -24.415% |
Radius Health, Inc. | 278.64 Million USD | 97.942% |
Universe Pharmaceuticals INC | 3.34 Million USD | -71.532% |
DURECT Corporation | 2.21 Million USD | -158.439% |
ProPhase Labs, Inc. | 3.84 Million USD | -49.304% |
Safety Shot Inc | 1.86 Million USD | -206.729% |
Phibro Animal Health Corporation | 265.91 Million USD | 97.843% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -608.207% |
Alvotech | 74.43 Million USD | 92.295% |
Assertio Holdings, Inc. | 37.68 Million USD | 84.783% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 92.592% |
Rockwell Medical, Inc. | 5.87 Million USD | 2.321% |
Procaps Group S.A. | 96.83 Million USD | 94.078% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 50.762% |
SCYNEXIS, Inc. | - USD | -Infinity% |
Aytu BioPharma, Inc. | 12.63 Million USD | 54.605% |
Viatris Inc. | 3.46 Billion USD | 99.835% |
OptiNose, Inc. | 8.05 Million USD | 28.779% |
SIGA Technologies, Inc. | 64.21 Million USD | 91.07% |
Tilray Brands, Inc. | 252.08 Million USD | 97.725% |
PetIQ, Inc. | 159.3 Million USD | 96.4% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 0.0% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 85.027% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -114.214% |
Alimera Sciences, Inc. | 1.87 Million USD | -205.203% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 82.263% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Organogenesis Holdings Inc. | 28.25 Million USD | 79.702% |
Journey Medical Corporation | 10.2 Million USD | 43.81% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -256.109% |
Alpha Teknova, Inc. | 11.59 Million USD | 50.537% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -27.922% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 85.656% |
PainReform Ltd. | - USD | -Infinity% |
Cosmos Health Inc. | 4.78 Million USD | -19.747% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 44.752% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 96.23% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 3853.652% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 104.35 Million USD | 94.504% |
Incannex Healthcare Limited | -10.01 Million USD | 157.262% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -2154.653% |
Shineco, Inc. | 1.58 Million USD | -261.011% |
Procaps Group, S.A. | 96.83 Million USD | 94.078% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 94.843% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 15.279% |
Lantheus Holdings, Inc. | 64.02 Million USD | 91.044% |
Alvotech | 74.43 Million USD | 92.295% |
Hempacco Co., Inc. | 2.54 Million USD | -125.544% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 88.001% |
Bright Green Corporation | - USD | -Infinity% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 91.261% |
Kamada Ltd. | 87.74 Million USD | 93.464% |
Indivior PLC | 141.79 Million USD | 95.956% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -1090.178% |
Flora Growth Corp. | 8.5 Million USD | 32.596% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -2154.653% |
Evolus, Inc. | 10.99 Million USD | 47.856% |
HUTCHMED (China) Limited | 50.25 Million USD | 88.589% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 94.581% |
Akanda Corp. | 1.28 Million USD | -345.628% |